{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:01:38Z","timestamp":1791910898672,"version":"4.3.4"},"reference-count":85,"publisher":"Korean Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["e-enm.org"],"crossmark-restriction":true},"short-container-title":["Endocrinol Metab"],"published-print":{"date-parts":[[2023,2,28]]},"abstract":"<jats:p>Chronic kidney disease (CKD) is the most common cause of end-stage renal disease in patients with type 2 diabetes mellitus (T2DM). CKD increases the risk of cardiovascular diseases; therefore, its prevention and treatment are important. The prevention of diabetic kidney disease (DKD) can be achieved through intensive glycemic control and blood pressure management. Additionally, DKD treatment aims to reduce albuminuria and improve kidney function. In patients with T2DM, renin-angiotensin-aldosterone system inhibitors, sodium glucose cotransporter 2 inhibitors, and glucagon-like peptide-1 receptor agonists can delay the progression of DKD. Hence, there is a need for novel treatments that can effectively suppress DKD progression. Finerenone is a first-in-class nonsteroidal mineralocorticoid receptor antagonist with clinically proven efficacy in improving albuminuria, estimated glomerular filtration rate, and risk of cardiovascular events in early and advanced DKD. Therefore, finerenone is a promising treatment option to delay DKD progression. This article reviews the mechanism of renal effects and major clinical outcomes of finerenone in DKD.<\/jats:p>","DOI":"10.3803\/enm.2022.1629","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T01:38:26Z","timestamp":1677548306000},"page":"43-55","update-policy":"https:\/\/doi.org\/10.3803\/crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease"],"prefix":"10.3803","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9206-3126","authenticated-orcid":true,"given":"Dong-Lim","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-520X","authenticated-orcid":true,"given":"Nan Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2119","reference":[{"key":"ref1","volume-title":"Trends in epidemiologic characteristics of end-stage renal disease from 2020 KORDS (Korean Renal Data System) [Internet]","year":"2022"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.09403.x"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.28996\/2618-9801-2021-2suppl-9-121"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2021.88660"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0027"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2016.31.2.245"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.01.005"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.050686"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2021.987"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000515622"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.604928"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15747"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa736"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.170"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa030207"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199909023411001"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.01040905"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1159\/000508670"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10081"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw132"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2025845"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2110956"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000441262"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.58"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0251"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.02.030"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1530\/joe-17-0060"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0465"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpy120"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m115.657957"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.114.04488"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ph14060561"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00313"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-005-2348-y"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.08r02cr"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2005040390"},{"key":"ref37","first-page":"652738","volume-title":"Modulation of immunity and inflammation by the mineralocorticoid receptor and aldosterone","author":"Munoz-Durango","year":"2015"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-019-02074-9"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20160086"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.8386"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2013.08.047"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1113\/jp277002"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvr131"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000211738.63207.c3"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2005111196"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/hjh.0000000000000259"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.121.17263"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000226054.53527.bb"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1159\/000480652"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000165889.60254.98"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00701.x"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011106"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1172\/jci118867"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.33.1.232"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.00240106"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.05.508"},{"key":"ref57","first-page":"173","volume-title":"Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review","author":"Mavrakanas","year":"2014"},{"key":"ref58","volume-title":"FDA approves drug to reduce risk of serious kidney and heart complications in adults with chronic kidney disease associated with type 2 diabetes [Internet]","year":"2021"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m110.131342"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-060821-013950"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002043rr"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1097\/fjc.0000000000000091"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa040135"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1009492"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab777"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.15841020"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2021070942"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht187"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)32135-x"},{"key":"ref70","first-page":"1407","volume-title":"Patiromer to enable spironolactone in patients with resistant hypertension and CKD (AMBER): results in the Prespecified Subgroup with Diabetes","author":"Agarwal","year":"2021"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-020-01342-w"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-021-00478-2"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1410853"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1411487"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2024816"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2204233"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00393-8"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1159\/000516213"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab336"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/ehaa946.0939"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab497"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.045691"},{"key":"ref83","first-page":"131","volume-title":"Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial","author":"Gerstein","year":"2019"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(19)30249-9"},{"key":"ref85","first-page":"125","volume-title":"Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: a subgroup analysis from the FIDELIO-DKD trial","author":"Rossing","year":"2022"}],"container-title":["Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-enm.org\/upload\/pdf\/enm-2022-1629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-enm.org\/journal\/view.php?doi=10.3803\/EnM.2022.1629","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-enm.org\/upload\/pdf\/enm-2022-1629.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T05:53:46Z","timestamp":1683006826000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-enm.org\/journal\/view.php?doi=10.3803\/EnM.2022.1629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"URL":"https:\/\/doi.org\/10.3803\/enm.2022.1629","relation":{},"ISSN":["2093-596X","2093-5978"],"issn-type":[{"value":"2093-596X","type":"print"},{"value":"2093-5978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"2022-11-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-27","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-28","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}